STAGE 0IS BLADDER CANCER AJCC V8
Clinical trials for STAGE 0IS BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE 0IS BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE 0IS BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New nanoparticle therapy targets bladder cancer cells
Disease control Recruiting nowThis early-stage trial tests a new treatment called PLZ4-coated paclitaxel-loaded micelles (PPM) for people with non-muscle invasive bladder cancer that has come back or not responded to standard therapy. PPM is a nanoparticle designed to deliver chemotherapy directly to tumor ce…
Matched conditions: STAGE 0IS BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New vaccine combo aims to train immune system to fight bladder cancer
Disease control Recruiting nowThis early-stage trial is testing a new peptide vaccine (IO102-IO103) combined with the immunotherapy drug pembrolizumab (Keytruda) in 30 adults with high-risk non-muscle invasive bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine is de…
Matched conditions: STAGE 0IS BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Bladder cancer chemotherapy comes home: new trial tests convenience and safety
Symptom relief Recruiting nowThis study tests whether giving chemotherapy directly into the bladder at home is safe and acceptable for people with non-muscle invasive bladder cancer. About 40 participants will receive their usual medications—such as BCG, gemcitabine, docetaxel, or mitomycin—at home instead o…
Matched conditions: STAGE 0IS BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Bladder cancer patients step up: App-Based exercise trial aims to boost activity
Symptom relief Recruiting nowThis study compares a home-based physical activity program delivered through the ExerciseRx app to health education alone in 100 adults with non-muscle invasive bladder cancer. Participants will use a Fitbit to track steps, and the app will set personalized goals and provide enco…
Matched conditions: STAGE 0IS BLADDER CANCER AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC